TD Asset Management
WHWK

TD Asset Management’s Whitehawk Therapeutics WHWK Stock Holding History

TD Asset Management’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-48,166
Closed -$233K – 1458
2023
Q3 		$233K Buy
48,166
+24,083
+100% +$140K ﹤0.01% 1359
2023
Q2 		$165K Hold
24,083
– – ﹤0.01% 1376
2023
Q1 		$174K Hold
24,083
– – ﹤0.01% 1384
2022
Q4 		$309K Hold
24,083
– – ﹤0.01% 1354
2022
Q3 		$330K Hold
24,083
– – ﹤0.01% 1359
2022
Q2 		$297K Sell
24,083
-10,700
-31% -$159K ﹤0.01% 1354
2022
Q1 		$590K Hold
34,783
– – ﹤0.01% 1327
2021
Q4 		$840K Buy
+34,783
New +$873K ﹤0.01% 1306

Other funds holding WHWK

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TD Asset Management's WHWK Position: Q4 2023 in Review

TD Asset Management sold out of Whitehawk Therapeutics (WHWK) in Q4 2023, closing a stake of 48,166 shares — an estimated $233K sold.

TD Asset Management first reported a position in WHWK in Q4 2021 and held it in 8 quarters. The position peaked at $840K in Q4 2021. 65 funds tracked by Wall St. Rank hold WHWK as of Q4 2023.

  • TD Asset Management reported no remaining Whitehawk Therapeutics position as of Q4 2023 after selling out during the quarter.
  • TD Asset Management sold 48,166 Whitehawk Therapeutics shares in Q4 2023, an estimated $233K.
  • TD Asset Management first reported a position in Whitehawk Therapeutics in Q4 2021 and held it in 8 quarters.
  • TD Asset Management's Whitehawk Therapeutics position peaked at $840K in Q4 2021.
  • 65 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q4 2023.

Based on TD Asset Management's 13F filing for Q4 2023, filed 12 Feb 2024.